Download Synapses and Synaptic Transmission

Document related concepts

Biochemical cascade wikipedia , lookup

Paracrine signalling wikipedia , lookup

Obesogen wikipedia , lookup

Chemotaxis wikipedia , lookup

Glutamate receptor wikipedia , lookup

Lipid signaling wikipedia , lookup

Killer-cell immunoglobulin-like receptor wikipedia , lookup

G protein–coupled receptor wikipedia , lookup

Leukotriene B4 receptor 2 wikipedia , lookup

Purinergic signalling wikipedia , lookup

Signal transduction wikipedia , lookup

Cannabinoid receptor type 1 wikipedia , lookup

Chemical synapse wikipedia , lookup

Transcript
Synapses and Synaptic
Transmission
• Dr. Donald Allen
Learning Objectives
• Describe the basic features of a synapse.
• Describe the events that occur at a synapse from the time an action
potential reaches the synapse to the time when the neurotransmitter is
released.
• Describe the electrical changes that occur at the postsynaptic terminal.
• Describe the mechanism for presynaptic facilitation and presynaptic
inhibition.
• Explain the differences between ligand-gated ion channels and Gprotein mediated receptors.
• Identify the major second messenger systems in the nervous system.
• Identify the major neurotransmitter systems in the nervous system and
their major functions.
• Identify the primary excitatory and inhibitory neurotransmitters in the
brain and spinal cord.
• Describe the stages that occur in the life of a neurotransmitter
molecule, (including storage in vesicles, release into the synaptic cleft,
binding to receptors and either degradation or reuptake by the
presynaptic terminal) and identify drugs that may interfere at these
stages.
• Describe the mechanism and role of receptor regulation
• Describe the pathology of Lambert-Eaton syndrome and Myasthenia
Gravis.
What are synapses?
• What is their function?
Main Components of a Synapse
•
•
•
•
Presynaptic terminal
Postsynaptic terminal
Synaptic cleft
Vesicles
– Neurotransmitters
Where are Synapses located?
• A synapse is between the axon of the presynaptic
neuron and a region of the postsynaptic cell.
• Where do we see synapses on the postsynaptic
cell?
• Do synapses with different locations have
different functions?
AxoAxoAxo-
http://faculty.washington.edu/
chudler/synapse.html
How Synapses Function
1. Action potential reaches presynaptic terminal
2. Calcium enters presynaptic terminal
1. Voltage-gated calcium ion channels
3.
4.
5.
6.
Vesicles move toward release site
Presynaptic terminal releases neurotransmitter
Neurotransmitter binds to postsynaptic receptors
Membrane channel changes configuration and
ions enter postsynaptic cell
1. Can also activate intracellular messengers
What determines how much
neurotransmitter is released?
Electrical Potentials at the
Synapse
• Neurotransmitter binding to receptors can
open ion channels
• At the neuromuscular junction or at
axosomatic and axodendritic synapses, ion
channel opening can generate a local
postsynaptic potential
• The potentials can be depolarizing or
hyperpolarizing
Postsynaptic potentials
• Excitatory postsynaptic potential – EPSP
–
–
–
–
De- or hyper-polarization
Nicotinic ACh receptor – _____________
_____________ channels
_____________ channels
• Inhibitory postsynaptic potential – IPSP
– De- or hyper-polarization
– _____________ ion channels
– _____________ ion channels
Actions of EPSPs
• In nervous system
– EPSPs can summate to generate an action
potential
• _____________
• _____________
• At neuromuscular junction
– Each action potential in motor neuron produces
a sufficient EPSP in muscle that there is muscle
contraction
Actions of IPSPs
• IPSPs can inhibit the generation of an action
potential
• What happens when there are both EPSPs
and IPSPs at a postsynaptic neuron
Presynaptic Facilitation
• Where are the synapses
– Axo-
• Depolarization –
– Makes an action potential last ________ at the
second axon presynaptic terminal
• The number of calcium ions that enter the
presynaptic terminal is _____________
Presynaptic Facilitation
• The change in calcium ions causes more
vesicles to release their neurotransmitter
Presynaptic Inhibition
• Hyperpolarization –
– Makes an action potential last ________ at the
second axon presynaptic terminal
– The number of calcium ions that enter the
presynaptic terminal is _____________
– The change in calcium ions causes less vesicles
to release their neurotransmitter
Neurotransmitters and
Neuromodulators
• Neurotransmitter
– Excite or inhibit postsynaptic neuron
– Effect lasts less than 1/10th of a second
• Neuromodulator
– Effect G-proteins which activate second
messengers
– Longer lasting (minutes to days)
Functional and Anatomical
Organization of Neurochemical
Systems
• Local circuits
• Diffuse systems
• Relay systems
Classification of
Neurotransmitters and
Neuromodulators
•
•
•
•
•
Acetylcholine
Amino acids
Monoamines
Peptides
Other
Acetylcholine
• Cholinergic systems
• Receptors
–N
–M
Amanita muscaria
http://www.du.edu/~kinnamon/3640/neurotransmitters/
Acetylcholine Metabolism
• Acetyl-Coenzyme A and Choline
– Choline acetyltransferase (CAT)
• Acetylcholine
– Acetylcholinesterase (AChE)
• Acetate and Choline
Peripheral ACh
• Neuromuscular junction
– Receptor:
– Function:
• Autonomic nervous system
– Receptors:
– Function:
Central ACh
• Receptors
– Both nicotinic and muscarinic
• Function
– Autonomic regulation
– Selection of objects of attention
Amino Acids
• Main neurotransmitters of central nervous
system
• Excitatory amino acids
– Aspartate
– Glutamate
• Inhibitory amino acids
– Glycine
– Gamma-aminobutyric acid (GABA)
Glutamate
• Principal fast neurotransmitter
• Functions
– Learning
– Development
– Neuronal death after CNS injury
Inhibitory Amino Acids
• Glycine
– Inhibits postsynaptic membranes, particularly
in brainstem and spinal cord
• GABA
– Major inhibitory neurotransmitter in CNS
– Interneurons in spinal cord
– Receptors: GABAA and GABAB
• Both act to prevent excessive neural activity
• Blocking the effects of these
neurotransmitters can produce seizures
Monoamines
• Moderate sized group
–
–
–
–
Norepinephrine (noradrenaline)
Dopamine
Serotonin
Histamine
• Cell bodies of these neurons?
• Overall functions?
Catecholamines:
Dopamine and Norepinephrine
• Phenylalanine
• Tyrosine
• Dihydroxyphenylalanine (l-DOPA)
• Dopamine
Further metabolism of
catecholamines
• Dopamine
• Norepinephrine
• Epinephrine
Structure of some catecholamines
Dopamine
• Motor activity (Parkinson’s Disease)
– l-DOPA
• Cognition (Schizophrenia)
– Dopamine receptor blockers
• Motivation
– Addiction
• Cocaine
• Amphetamine
Norepinephrine
• Autonomic nervous system
– Fight or fight response
– Panic disorder
• Attention and Vigilance
Serotonin
• AKA 5-hydroxytryptamine
Serotonin functions
• Regulation of blood vessels
• Low levels of serotonin associated with
depression and suicide
– SSRI – selective serotonin reuptake inhibitors
• Fluoxetine (Prozac)
• Sleep
Histamine
• Concentrated in hypothalamus
• Helps regulate hormonal function
Peptides
•
•
•
•
Very broad category
Many different functions
More modulators than neurotransmitters
There are several families of peptides
Peptide release
• Many neurons contain both a peptide
neuromodulator and a more traditional
neurotransmitter
• With low stimulation, usually the neuron
releases just the neurotransmitter
• With high levels of stimulation, both the
peptide and the neurotransmitter are
released
Endogenous opioid peptides
• Bind to the same receptors that opiate drugs
bind to
• Three families
–
–
–
–
Endorphins
Enkephalins
Dynorphins
Each family comes from a different gene
• In general, involved in pain inhibition
• Endorphins and enkephalins involved in
‘runner’s high’
• Also important in regulation of hormonal
systems
Substance P
• P is for pain
• Substance P acts as a neurotransmitter in
some of the neurons in the sensory
pathways that relay pain sensation
Other peptides
•
•
•
•
•
ACTH (pituitary)
Vasopressin (pituitary)
Neurotensin
Cholecystokinin
Somatostatin (hypothalamus)
Miscellaneous Neurotransmitters
• Nitrous oxide
–
–
–
–
Neuromodulator
Regulates vascular systems
Cell death of neurons
Changes in postsynaptic neuron in response to repeated
stimuli
• Carbon monoxide
– Short-lasting, rapid effects
– Affects neurotransmitter release
Receptors
• Most neurotransmitters and neuromodulators act
by binding to specific proteins on the postsynaptic
membrane termed receptors
• Substances which bind to receptors are called
ligands
• Most receptors named after the ligand that binds to
them
– Some important exceptions
Types of Receptors
• Ligand-gated ion channels
• G-protein mediated receptors
Ligand-gated ion channels
• Receptor and ion channel are the same complex
• Actions usually rapid and brief
• Mechanism
–
–
–
–
Ligand binds to receptor
Ion channel opens
Ions travel through channel
Local membrane depolarization or hyperpolarization
Nicotinic Acetylcholine Receptor
• Located at neuromuscular junction
• Best studied receptor
• Made up of 5 subunits
Nicotinic AChR
• Two molecules of ACh bind to the receptor
• Ion channel opens
– Permeable to both Na+ and K+
– Overall effect is depolarization
• More Na+ enters than K+ leaves the muscle fiber
– Channel open for only a few milliseconds
• Action at the receptor ends when:
– Neurotransmitter diffuses away from the synaptic
cleft
– Neurotransmitter is broken down into an inactive
form
• Acetylcholinesterase (ACh)
• Monoamine oxidase (monoamines)
• Peptidases (peptide neuromodulators)
– Neurotransmitter is taken up into the presynaptic
terminal
G-protein mediated receptors
• AKA: 7-transmembrane receptor
– Picture next slide
• Effects slower and longer lasting
–
–
–
–
Open/close ion channel
Activate/inhibit enzymes
Regulate calcium levels in cell
Activate/inactivate genes
Beta-2 adrenergic receptor
Mechanism of Action
• Can be stimulatory, inhibitory or modulatory
• Involve activation/inhibition of second messenger
systems
– Note that this can give us amplification of the ligand.
One ligand-activated receptor can produce multiple 2nd
messengers. If the 2nd messengers activate enzymes,
we have a further magnification of the response
Second messengers
• Cyclic AMP (cAMP)
– Modulates ion channels (pain sensation in PNS)
– Activates cAMP dependent proteins/enzymes
• Arachidonic acid – derived from lipids
– Produces prostaglandins – aspirin blocks PG synthesis
• regulate vasodilation
• Enhances inflammation
• Inositol triphosphate
– Regulates Calcium ion stores
G-protein action
cAMP as 2nd Messenger
G-protein action
Phosphoinositol as 2nd Messenger
Types of Receptors
•
•
•
•
•
•
Acetylcholine
Aminoacid
Norepinephrine
Dopamine
Serotonin
Opioid peptide
Acetylcholine Receptors
• Nicotinic – ligand-gated ion channel
– Neuromuscular junction
– Autonomic ganglia
– Some parts of CNS
• Functions
– Memory and learning
• Alzheimer’s disease
– Neuronal development
Muscarinic Acetylcholine
Receptors
• G-protein linked receptors
– Autonomic targets – heart
– Selected areas of brain
• Autonomic function – Parasympathetic
– Slow heart
Glutamate Receptors
• Both ion channels and G-protein linked
• Ion Channels – named for drugs that bind
– AMPA – fast acting
– Kainate – fast acting
– NMDA – slow opening and closing of ion
channels
• G-protein – metabotropic receptors
NMDA receptors
• Function
– Normal neurotransmission
– Long-term changes in the CNS
• Long-term potentiation (next section)
• Learning and memory
NMDA receptors and pathology
• Neuronal cell death
– Injury to part of the brain can produce cell death in
surrounding regions
• Overactivity may cause epileptic seizures
• Phencylclidine (PCP, angel dust) acts on NMDA
receptors
• Other pathologies
– Acute stroke, chronic pain, Parkinson’s disease,
schizophrenia
GABA receptors
• GABA-A receptors
– Chloride ion-channel linked
– Effect on cell membrane?
– Barbiturates bind
• Sedation
• Decrease anxiety (anxiolytic)
• Anticonvulsants for treating seizures
• GABA-B receptors
– G-protein mediated
– Linked to ion channels through 2nd messengers
• Baclofen – muscle relaxant
• All GABA receptors tend to be inhibitory
Dopamine Receptors
• Dopaminergic receptors
– 5 types – D1, D2, D3, D4, D5
– Main types
• D1, also D3, D5
• D2, also D4
• D1 and D2 can have the opposite effects
Norepinephrine receptors
• Alpha-receptors (alpha-1 and alpha-2)
• Beta-receptors (beta-1 and beta-2)
– Beta-1
• Heart: increase force and rate of contraction
• Beta-blockers
– Beta-2
• Lungs: bronchodilation
• Inhalers for asthma
Serotonin receptors
• 5-HT receptors
– Multiple types
•
•
•
•
•
Cognition
Sleep
Perception (including pain)
Motor activity
Mood
Opioid peptide receptors
• Several types
– Mu
– Delta
– Kappa
• Primary action is inhibition of slow pain
information
• Location: hypothalamus, spinal cord, and
periaqueductal gray
How can we change synaptic
transmission?
• Drugs can interfere at many different stages
–
–
–
–
–
–
–
Synthesis of neurotransmitter
Packaging in vesicles
Regulating calcium ions in presynaptic terminal
Release of neurotransmitter from vesicles
Binding of neurotransmitter to receptors
Degradation of neurotransmitter
Re-uptake of neurotransmitter
Synthesis of Neurotransmitter
• l-DOPA
Packaging in vesicles
• Reserpine
Calcium Ion regulation
• Lambert-Eaton syndrome
Neurotransmitter release
• Botulinum toxin poisoning
– Blocks release of ACh at the neuromuscular
junction
– Used to treat (short-term) spasticity
– Used for cosmetic reasons
Receptor binding
• Agonists
• Antagonists
• Myasthenia gravis
Neurotransmitter Degradation
• Monoamine oxidase inhibitors (MAO-I)
• Acetylcholinesterase inhibitors
Neurotransmitter Reuptake
• Tricyclic antidepressants
– Inhibit monoamine reuptake
– Tend to act at cholinergic receptors also
• Selective serotonin reuptake inhibitors
– Prozac (serotonin)
Lambert-Eaton Syndrome
• Mostly seen in patients with cancer, usually small
cell carcinoma of the lung
• Antibodies are produced against voltage-gated
calcium channel of the neuromuscular junction
• Antibodies block calcium entry into presynaptic
terminal
• What affect will this have on ACh release and
muscle strength?
Myasthenia gravis
• Antibodies to the nicotinic acetylcholine
receptor
• Antibody blocks the effect of ACh on the
muscle
– Increasing weakness seen with repeated use of
a muscle
– Initial sign in about 50% of patients
• Weakness opening eyelids or moving eyes. Why?
• Other muscles commonly affected
–
–
–
–
Facial muscles
Muscles for swallowing
Proximal limb muscles
Respiratory muscles
• Demographics of onset
– Women: 20-30
– Men: 60-70
Treatment
•
•
•
•
Acetylcholinesterase inhibitors
Removal of thymus gland
Immunosuppressive drugs
Plasmapheresis: removes antibodies
Questions before Chapter 4